ATE421318T1 - Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben - Google Patents

Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben

Info

Publication number
ATE421318T1
ATE421318T1 AT98907531T AT98907531T ATE421318T1 AT E421318 T1 ATE421318 T1 AT E421318T1 AT 98907531 T AT98907531 T AT 98907531T AT 98907531 T AT98907531 T AT 98907531T AT E421318 T1 ATE421318 T1 AT E421318T1
Authority
AT
Austria
Prior art keywords
dosage form
production
application
same
dispersion properties
Prior art date
Application number
AT98907531T
Other languages
English (en)
Inventor
Jaedeok Yoo
Sandeep Kumar
Donald Monkhouse
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE421318T1 publication Critical patent/ATE421318T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00—Products made by additive manufacturing
AT98907531T 1997-02-20 1998-02-20 Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben ATE421318T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3888397P 1997-02-20 1997-02-20
US3828497P 1997-02-20 1997-02-20

Publications (1)

Publication Number Publication Date
ATE421318T1 true ATE421318T1 (de) 2009-02-15

Family

ID=26715043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907531T ATE421318T1 (de) 1997-02-20 1998-02-20 Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben

Country Status (9)

Country Link
US (3) US6471992B1 (de)
EP (1) EP0973507B1 (de)
JP (3) JP4563516B2 (de)
AT (1) ATE421318T1 (de)
AU (1) AU736912B2 (de)
CA (1) CA2281473C (de)
DE (1) DE69840495D1 (de)
ES (1) ES2318869T3 (de)
WO (1) WO1998036738A1 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4563516B2 (ja) 1997-02-20 2010-10-13 マサチューセッツ インスティテュート オブ テクノロジー 迅速分散性を示す投与剤形、その使用法並びにその製造方法
AU3731699A (en) * 1998-05-18 1999-12-06 Takeda Chemical Industries Ltd. Orally disintegrable tablets
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
EP1301177A2 (de) * 2000-07-10 2003-04-16 Therics, Inc. Verfahren und materialien zur steuerung der wanderung einer binderflüssigkeit in ein pulver
KR20090029314A (ko) * 2001-06-28 2009-03-20 유씨비 파쉼 소시에떼아노님 세티리진 및 슈도에페드린을 포함하는 정제
IL159715A0 (en) * 2001-07-10 2004-06-20 Teva Pharma Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
EP1439945B1 (de) * 2001-10-29 2006-04-12 Therics, Inc. System und verfahren zum uniaxialen pressen eines gegenstandes wie eine drei-dimensional gedruckte dosierungsform
CA2463481A1 (en) * 2001-10-29 2003-05-22 Therics, Inc. Three-dimensional suspension printing of dosage forms
DE60323482D1 (de) * 2002-05-06 2008-10-23 Massachusetts Inst Technology Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
AU2003280324A1 (en) * 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
MX2007003032A (es) 2004-09-21 2007-05-21 Hypnion Inc Analogos de loxapina y metodos de uso de los mismos.
US7829000B2 (en) * 2005-02-25 2010-11-09 Hewlett-Packard Development Company, L.P. Core-shell solid freeform fabrication
US8187659B2 (en) 2006-05-02 2012-05-29 Jerry Robertson Real Estate Llc Solid medicament dosage form consumption aid
ES2500165T3 (es) 2006-06-29 2014-09-30 Kinex Pharmaceuticals, Llc Composiciones de biarilo y métodos para modular una cascada de quinasas
CN101932319A (zh) 2007-10-20 2010-12-29 金克斯医药品有限公司 用于调控激酶级联的药物组合物以其使用方法
MY150626A (en) 2009-10-30 2014-02-07 Ix Biopharma Ltd Fast dissolving solid dosage form
EP3195858B1 (de) * 2010-04-03 2019-08-07 Praful Doshi Medizinische vorrichtungen mit medikamenten sowie verfahren zu ihrer herstellung und verwendung
WO2012056319A1 (en) 2010-10-27 2012-05-03 Dynamix Pharmaceuticals Ltd. Sulfonamides for the modulation of pkm2
US8987271B2 (en) 2010-12-22 2015-03-24 Eutropics Pharmaceuticals, Inc. 2,2′-biphenazine compounds and methods useful for treating disease
US8722636B2 (en) 2011-01-31 2014-05-13 New Market Pharmaceuticals, LLC Animal treatments
EP2684167B1 (de) 2011-03-08 2020-09-09 Eutropics Pharmaceuticals, Inc. Zusammensetzungen und verfahren zur behandlung von erkrankungen
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
WO2012160447A1 (en) 2011-05-25 2012-11-29 Dynamix Pharmaceuticals Ltd. 3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
US8937065B2 (en) 2011-06-07 2015-01-20 Clevexel Pharma Compositions and methods for modulating a kinase
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
US9245061B2 (en) * 2012-04-25 2016-01-26 Shapeways, Inc. Weight-based identification of three dimensional printed parts
CA2872396C (en) 2012-05-02 2022-12-13 Newmarket Pharmaceuticals Llc Pharmaceutical compositions for direct systemic introduction comprising a proton pump inhibitor
WO2013192423A2 (en) 2012-06-20 2013-12-27 Eutropics Pharmaceuticals, Inc. Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
CN105263907B (zh) 2012-08-30 2018-11-20 阿西纳斯公司 作为蛋白质酪氨酸激酶调节剂的n-(3-氟苄基)-2-(5-(4-吗啉代苯基)吡啶-2-基)乙酰胺
US9545376B2 (en) 2013-01-23 2017-01-17 Arx, Llc Production of unit dose constructs
AU2014228861B2 (en) 2013-03-15 2018-05-24 Aprecia Pharmaceuticals LLC Rapidly dispersible dosage form of topiramate
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
CA2906107C (en) * 2013-03-15 2021-08-24 Aprecia Pharmaceuticals Company Rapidly dispersible dosage form of oxcarbazepine
CA2906029C (en) * 2013-03-15 2017-09-05 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
WO2014176389A1 (en) 2013-04-24 2014-10-30 Temple University - Of The Commonwealth System Of Higher Education Solid dosage form containing arabinogalactan
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
JP6233996B2 (ja) 2013-08-16 2017-11-22 ザ エクスワン カンパニー ３次元印刷される金属鋳造用鋳型及び同鋳型の製造方法
EP3057729A4 (de) 2013-10-17 2017-10-18 The Exone Company Isostatische heisspressbehälter mit 3d-druck und verfahren zur herstellung davon
US20160332373A1 (en) 2013-12-23 2016-11-17 The Exone Company Methods and Systems for Three-Dimensional Printing Utilizing Multiple Binder Fluids
WO2015100084A1 (en) 2013-12-23 2015-07-02 The Exone Company Method of three-dimensional printing using a multi-component build powder
EP3086921B1 (de) * 2013-12-23 2019-07-31 The Exone Company Verfahren und systeme zum dreidimensionalen drucken unter verwendung einer bindemittelflüssigkeit mit ausgestrahlten partikeln
US20160184230A1 (en) * 2014-04-30 2016-06-30 Aron H. Blaesi Melt-processed polymeric cellular dosage form
WO2015183796A1 (en) 2014-05-29 2015-12-03 The Exone Company Process for making nickel-based superalloy articles by three-dimensional printing
WO2016011098A2 (en) 2014-07-17 2016-01-21 The Exone Company Methods and apparatuses for curing three-dimensional printed articles
MX368838B (es) 2014-11-21 2019-10-18 Biohaven Pharm Holding Co Ltd Administracion sublingual de riluzol.
KR102411873B1 (ko) 2014-12-03 2022-06-21 더 엑스원 컴퍼니 3차원 프린팅에 의해 고밀화 탄소 물품을 제조하는 공정
EP3302442A4 (de) 2015-06-03 2019-02-06 Triastek, Inc. Darreichungsform und verwendung davon
EP3108874A1 (de) * 2015-06-26 2016-12-28 TRB Chemedica AG Pharmazeutische zubereitung zur anwendung am auge
US11129798B2 (en) * 2016-08-19 2021-09-28 Aron H. Blaesi Fibrous dosage form
CA3018012A1 (en) * 2016-03-18 2017-09-21 Grunenthal Gmbh Combination of drugs having different potency
EP3441065A4 (de) * 2016-04-06 2019-11-20 Astellas Pharma Inc. Schnell eluierendes dreidimensionales formteil, filament für ein schnell eluierendes dreidimensionales formteil und material für ein schnell eluierendes dreidimensionales formteil
EP3452003A4 (de) 2016-05-05 2019-06-26 Triastek, Inc. Dosierungsform mit kontrollierter freisetzung
RS62935B1 (sr) 2016-05-20 2022-03-31 Biohaven Therapeutics Ltd Primena riluzola, prolekova riluzola ili analoga riluzola sa imunoterapijama za lečenje kancera
TWI755418B (zh) 2016-08-12 2022-02-21 美商亞瑟尼克斯公司 聯芳組成物和調控激酶級聯之方法
EP3529023B1 (de) 2016-10-19 2022-05-25 Shapeways, Inc. Systeme und verfahren zur identifizierung dreidimensionaler druckobjekte
CA3045043A1 (en) 2016-12-31 2018-07-05 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
US11602502B2 (en) 2017-02-24 2023-03-14 Hewlett-Packard Development Company, L.P. Three-dimensional (3D) printing a pharmaceutical tablet
CN110381925A (zh) 2017-03-08 2019-10-25 辛瑞克斯制药有限公司 间苯三酚和三甲基间苯三酚的药物制剂
EP3635045A1 (de) 2017-05-26 2020-04-15 Infinite Material Solutions, LLC Wasserlösliche polymerzusammensetzungen
EP3706739A4 (de) 2017-11-12 2021-08-04 Biohaven Pharmaceutical Holding Company Ltd. Verwendung von riluzolprodrugs zur behandlung von ataxien
CN108066302B (zh) * 2017-12-28 2020-09-11 无限极（中国）有限公司 一种快速分散固体制剂的制备方法及制备的快速分散固体制剂
US10350822B1 (en) 2018-01-09 2019-07-16 Triastek Inc. Dosage forms with desired release profiles and methods of designing and making thereof
CN116270513A (zh) 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
DE102018107585B3 (de) * 2018-03-29 2019-03-28 Universität Rostock Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen
CN115154440A (zh) 2018-06-27 2022-10-11 比奥克斯塞尔医疗股份有限公司 含右美托咪定的膜制剂及其制造方法
CN112867482B (zh) 2018-10-15 2023-04-25 阿普雷奇亚制药有限责任公司 在包装内形成剂型的方法和系统
US20220016074A1 (en) 2018-11-21 2022-01-20 Rosemont Pharmaceuticals Limited Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
JP7287032B2 (ja) 2019-03-20 2023-06-06 株式会社リコー シート、シート積層体、医薬品、シートの製造方法、及びシート積層体の製造方法
EP3972567A1 (de) * 2019-05-21 2022-03-30 DFE Pharma GmbH & Co. KG Dreidimensionales laktosepulverbettdrucken
BR112022000992A2 (pt) 2019-07-19 2022-06-14 Arx Llc Regimes de tratamento de dexmedetomidina não sedantes
TWI734309B (zh) * 2019-12-19 2021-07-21 水星生醫股份有限公司 滲透性噴塗製作藥錠裝置
CA3183295A1 (en) 2020-06-26 2021-12-30 Jaedeok Yoo Rapidly-orodispersible tablets having an interior cavity
US20230390193A1 (en) 2020-10-30 2023-12-07 Triastek, Inc. Gastroretentive pharmaceutical dosage form

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4642903A (en) 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
US4855326A (en) 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
FR2647343B1 (fr) * 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5204055A (en) 1989-12-08 1993-04-20 Massachusetts Institute Of Technology Three-dimensional printing techniques
US5578322A (en) 1990-11-30 1996-11-26 Yamanouchi Pharmaceutical Co., Ltd. Quick release coated preparation
ES2081564T3 (es) 1991-01-31 1996-03-16 Texas Instruments Inc Metodo y sistema para la fabricacion, controlada por ordenador, de objetos tridimensionales a partir de datos de ordenador.
DK0617613T3 (da) * 1991-12-20 1996-06-17 Pfizer Porøse formgivne afgivelsesindretninger og fremgangsmåde til fremstilling deraf
JP2521612B2 (ja) * 1992-05-20 1996-08-07 ウエイ・ミン・フアーマシユーテイカル・マニユフアクチヤリング・カンパニー・リミテツド 直接錠剤形成助剤
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5380473A (en) 1992-10-23 1995-01-10 Fuisz Technologies Ltd. Process for making shearform matrix
DE4303846A1 (de) * 1993-02-10 1994-08-11 Merck Patent Gmbh Verfahren zur Herstellung einer S-Ibuprofen enthaltenden Tablette
WO1995001782A2 (en) * 1993-07-09 1995-01-19 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
US6176874B1 (en) 1993-10-18 2001-01-23 Masschusetts Institute Of Technology Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
US6280771B1 (en) 1997-02-20 2001-08-28 Therics, Inc. Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof
US5490962A (en) 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US5503785A (en) 1994-06-02 1996-04-02 Stratasys, Inc. Process of support removal for fused deposition modeling
US5633021A (en) 1994-10-19 1997-05-27 Bpm Technology, Inc. Apparatus for making a three-dimensional article
US5607697A (en) 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
US5560927A (en) * 1995-07-28 1996-10-01 Isp Investments Inc. Co-processing method for making a free-flowing compressible powder and tablet therefrom
US5653925A (en) * 1995-09-26 1997-08-05 Stratasys, Inc. Method for controlled porosity three-dimensional modeling
JP4563516B2 (ja) * 1997-02-20 2010-10-13 マサチューセッツ インスティテュート オブ テクノロジー 迅速分散性を示す投与剤形、その使用法並びにその製造方法
DE19940944B4 (de) * 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen

Also Published As

Publication number Publication date
US20120207929A1 (en) 2012-08-16
JP2010120938A (ja) 2010-06-03
US20030133975A1 (en) 2003-07-17
EP0973507A1 (de) 2000-01-26
AU736912B2 (en) 2001-08-02
DE69840495D1 (de) 2009-03-12
EP0973507A4 (de) 2006-08-23
JP2009215305A (ja) 2009-09-24
WO1998036738A1 (en) 1998-08-27
US6471992B1 (en) 2002-10-29
ES2318869T3 (es) 2009-05-01
US9463160B2 (en) 2016-10-11
CA2281473C (en) 2007-01-16
AU6331498A (en) 1998-09-09
JP4563516B2 (ja) 2010-10-13
CA2281473A1 (en) 1998-08-27
US9114072B2 (en) 2015-08-25
EP0973507B1 (de) 2009-01-21
JP2001512488A (ja) 2001-08-21
JP5091910B2 (ja) 2012-12-05

Similar Documents

Publication Publication Date Title
ATE421318T1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
DE69704426D1 (de) Verfahren zur herstellung von medizinischem kaugummi mit einem guten geschmack, enthaltend eine einschlussverbindung
AU3951399A (en) Stable gel mixture in the form of a mixture of oleogel and aqueous gel
HUP9903334A2 (hu) Eljárás morfológiailag egységes mikrokapszulák előállítására, valamint az ezzel az eljárással előállított mikrokapszulák
NO962088D0 (no) Preparat for in vivo-produksjon av terapeutiske produkter
ES2094781T3 (es) Composicion farmaceutica de microparticulas con liberacion controlada y su proceso de preparacion.
EP0158277A3 (de) Implantierbare Zubereitungen von regulatorischen Peptiden mit gesteuerter Freisetzung und Verfahren zur ihrer Herstellung
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
CA2233961A1 (en) Stimulation of hair follicles
YU66600A (sh) Farmaceutski preparati koji mogu da budu gelirani
ATE149826T1 (de) Verfahren zur herstellung von festen pharmazeutischen retardformen
ATE249819T1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
ATE258044T1 (de) Verfahren zur herstellung einer mit bändern versehenen dosisform zur verlängerten freisetzung eines wirkstoffs
DE69024363D1 (de) Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
DE69001573T2 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
DE69527711D1 (de) Verfahren und apparat zur herstellung von schnelllöslichen dosierungseinheiten und daraus erhältliches produkt
AP1919A (en) Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same
ATE282406T1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
DE60000286T2 (de) Lipide enthaltende sojaextrakte, verfahren zu deren herstellung und pharmazeutische und kosmetische zusammensetzung
ATA379182A (de) Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
HUP9902032A2 (hu) Peszticid készítmény
WO2001015547A3 (de) Wirkstoffpräparat für tierärztliche applikation und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties